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ABSTRACT
Empirical scoring functions based on either molecular force fields or cheminformatics descriptors are widely used, in conjunction
with molecular docking, during the early stages of drug discovery to predict potency and binding affinity of a drug-like molecule
to a given target. These models require expert-level knowledge of physical chemistry and biology to be encoded as hand-tuned
parameters or features rather than allowing the underlying model to select features in a data-driven procedure. Here, we
develop a general 3-dimensional spatial convolution operation for learning atomic-level chemical interactions directly from
atomic coordinates and demonstrate its application to structure-based bioactivity prediction. The atomic convolutional neural
network is trained to predict the experimentally determined binding affinity of a protein-ligand complex by direct calculation
of the energy associated with the complex, protein, and ligand given the crystal structure of the binding pose. Non-covalent
interactions present in the complex that are absent in the protein-ligand sub-structures are identified and the model learns
the interaction strength associated with these features. We test our model by predicting the binding free energy of a subset
of protein-ligand complexes found in the PDBBind dataset and compare with state-of-the-art cheminformatics and machine
learning-based approaches. We find that all methods achieve experimental accuracy (less than 1 kcal/mol mean absolute error)
and that atomic convolutional networks either outperform or perform competitively with the cheminformatics based methods.
Unlike all previous protein-ligand prediction systems, atomic convolutional networks are end-to-end and fully-differentiable.
They represent a new data-driven, physics-based deep learning model paradigm that offers a strong foundation for future
improvements in structure-based bioactivity prediction.
Introduction
The success rate of the initial phases of drug discovery depends on the prediction, or measurement, of the affinity of a candidate
ligand for a therapeutic target (e.g., protein) of interest. The space of synthetically accessible small molecules is unfathomably
vast, estimated at over 1060 compounds1. While exploring this entire space is currently computationally intractable, this
combinatorial explosion underscores a core challenge in drug discovery: testing the affinity of as many small molecules as
possible while maintaining a sufficient degree of accuracy. There is currently a significant trade-off in both experimental and
computational drug screening approaches between speed, cost, and accuracy.2–4
The introduction of machine learning into drug discovery pipelines has improved virtual drug screening as well as other
physics-based evaluations of small molecules. Models such as random forests, logistic regression, and support vector machines5
have been used extensively in virtual screening and chemoinformatics in the past decade and beyond. However, such models
were beset by a fundamental limitation: the need to represent molecules with hand-curated, fixed-length vector features.
More recently, deep learning has demonstrated the potential to exceed this inherent limitation in traditional machine learning.
The flexibility of deep neural networks allows models in principle to “learn” successively higher orders of features from the
simplest possible representations of the data at hand. In the computer vision field, for example, convolutional neural networks6
applied to images can learn how to detect edges in early layers in the network; eyes, ears, etc. in intermediate network layers;
and finally faces in terminal layers of the network. While such advanced artificial neural network frameworks have led to
immense advances in the fields of computer vision and natural language processing, they have only recently penetrated other
areas.
The promise of DNNs has only just begun to be realized in the fields of chemistry and physics. Scientists have demonstrated
the use of neural networks for molecular force fields7, 8, prediction of electronic properties of small molecules9, protein-ligand
binding10–12, chemoinformatics13–15, among others. Previous works that addressed protein-ligand binding have used simpler,
fully connected neural networks based on hand-curated features10 or used a direct application of voxel-based convolutional
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Figure 1. Schematic of atomic convolution layer.
neural networks in the two-class classification task of distinguishing small molecule binders from non-binders.11, 12 The atomic
convolution architecture was inspired by the atomic fingerprint neural network, originally proposed by Behler and Parrinello7, 8
for the purpose of fitting potential energy surfaces, with several key differences. Rather than choose fixed parameters for
the featurization of molecules into atomic fingerprint vectors, we optimize these parameters simultaneously with the neural
network in an end-to-end fashion to allow the model to make data-driven decisions on features that are important to predicting
ligand binding. In addition, we utilize a neighbor list routine to reduce the computational cost of model training and evaluation,
allowing the models to scale well to large systems. This work represents the largest application of this method to date and the
first application based purely on experimental data.
In this paper, we introduce a new fundamental deep learning primitive to improve the representational and predictive power
for molecular systems, the Atomic Convolutional Neural Network (ACNN). Analogous to the original CNNs6, 16, ACNN’s
directly exploit the local three-dimensional structure of molecules to hierarchically learn more complex chemical features by
optimizing both the model and featurization simultaneously in an end-to-end fashion. Whereas many previous works focus on
two-class classification of drug binding or non-binding, we apply ACNNs to directly predict binding free energy arising from
non-covalent interactions purely from experimental data by direct integration of a ligand-binding thermodynamic cycle into the
model optimization. The resulting optimized energy function is size-extensive and fully-differentiable with respect to atomic
coordinates. In addition, ACNN models have the desirable feature of being able to generalize to larger systems than those it has
been trained on. After describing the mathematical architecture of the ACNNs, we report their application for the prediction of
protein-ligand binding affinity with the publicly available PDBBind dataset.17 All calculations were done in the open-source
molecular machine learning package DeepChem.18 We open source all datasets and code required to reproduce this work.
Methods
Atomic Convolutional Neural Networks
The architecture of the atomic convolutional neural network is shown in Figure 1. We introduce two new primitive convolutional
operations, atom type convolution and radial pooling. The atom type convolution makes use of a neighbor-listed distance matrix
to extract features encoding local chemical environments from an input representation (Cartesian atomic coordinates) that does
not necessarily contain spatial locality.
Distance matrix and neighbor list construction
The distance matrix R and atomic number matrix Z are constructed from the Cartesian atomic coordinates X . We use a neighbor
list routine19 to reduce the complexity of this step from O(N2) to O(NM), where M is some maximum number of neighbors.
The radial interaction cutoff used in the neighbor list routine is 12 A˚ and the neighbor list is truncated at number of neighbors
M, typically 12. The initial neighbor list distance matrix representation is invariant to rigid body translation and rotation of the
molecular system but not atom index or neighbor list atom index permutation.
The distance matrix construction accepts as input a (N,3) coordinate matrix C. This matrix is “neighbor listed” into a
(N,M) matrix R. For atom i, the neighbor listing process finds the M atoms closest to i spatially. Let Ni = [ai1 , . . . ,aim ] be the
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list of neighbors. Then Ri, j is defined as
Ri, j = ‖Ci−Ci j‖2
The neighbor listing operation also constructs from the (N,1) atomic number vector z a (N,M) matrix Z which lists the atomic
number of neighboring atoms (atom types).
Zi, j = Atom type of ai j
Atom type convolution
The output of the atom type convolution is constructed from the distance matrix R and atomic number matrix Z. The matrix R
is fed into a (1x1) filter with stride 1 and depth of Nat, where Nat is the number of unique atomic numbers (atom types) present
in the molecular system. The atom type convolution kernel is a step function that operates on neighbor distance matrix R:
(K ∗R)i, j = Ri, jKai, j
where
Kai, j =
{
1 Zi, j = Na
0 otherwise
where Na is the atomic number of atom type a (a = 1, . . . ,Nat). The atom type convolution layer is applied to the neighbor
distance matrix to create output matrix E of shape (N,M,Nat). The atom type convolution can also be thought of as an expansion
layer that one-hot encodes the atom type Na into separate copies of the distance matrix RNa .
Radial pooling layer
Radial pooling is a dimensionality reduction process intended to down-sample the output of the atom type convolution.
This dimensionality reduction is done in part to prevent over-fitting by providing an abstracted form of the representation
through feature binning, as well as reducing the number of parameters learned. In addition, radial pooling provides an output
representation invariant to neighbor list atom index permutation.
Radial pooling takes input tensor E output by the atom-type convolution of shape (N,M,Nat). Radial pooling is then
performed by applying a radial filter over non-overlapping sub-regions of the input representation. Mathematically, radial
pooling layers pool over tensor slices (receptive fields) of size (1xMx1) with stride 1 and a depth of Nr, where Nr is the number
of desired radial filters. Radial pooling filters are of the functional form fs
fs(ri, j) = exp
(
− (ri, j−rs)2σ2s fc(ri, j)
)
fc(ri, j) =
{
1
2 cos
(
piri, j
Rc
)
0 < ri, j < Rc
0 ri, j ≥ Rc
Parameters rs and σs are learn-able parameters for pooling function fs. Parameter Rc is the radial interaction cutoff, which
is fixed to 12 A˚. Then, the output pooled matrix P is of shape (N,Nat,Nr) and has entries
Pi,na,nr = βnr
M
∑
j=1
fnr(Ei, j,na)+bnr
where βnr is the non-learn-able scaling constant and bnr is a non-learn-able bias constant. Conceptually, applying radial pooling
following an atom type convolution layer produces features which sum the pairwise-interactions between atom i with atom type
ai (e.g. H, C, N, etc.) and all neighboring atoms of type a j (e.g. H-H, H-C, H-N, etc.).
Atomistic fully connected network
The output P of the radial pooling layer has shape (N,Nat,Nr). We flatten the coordinates for each atom to obtain a tensor of
shape (N,Nat ·Nr). Atomic convolution layers can be stacked by feeding the flattened output of the radial pooling layer back
into the atom-type convolution operation. Finally, we feed the tensor row-wise (per-atom) into a fully-connected network. The
same fully connected weights and biases are used for each atom in a given molecule. The output of the atomistic fully-connected
network is energy Ei of atom i (i = 1 · · ·N). The total energy of the molecule, E = ∑i Ei, is the sum of the atomic energies and
is consequently invariant to atom index permutation. Since the fully connected network input dimension only depends on the
number of features, not number of atoms, a fully trained ACNN model can generalize to systems larger than those contained in
the training set, given a fixed number of atom types and radial pooling filters.
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Figure 2. Diagram of Atomic Convolutions on Protein Ligand Systems.
Application of atomic convolution networks to predicting protein-ligand binding affinity
The atomic convolution network architecture produces an energy that is size-extensive and differentiable with respect to atomic
positions. In order to learn non-covalent interactions using the atomic convolution energy function, we integrate the following
thermodynamic cycle into the learning process
∆Gcomplex = Gcomplex−Gprotein−Gligand
To create a model which can accurately predict ∆Gcomplex, we create three weight-sharing, replica networks, one each for
complex, protein, and ligand (Figure 2). The full system is trained against the loss
L = (∆Gcomplex− ycomplex)2
Note how the complete network incorporates the thermodynamic cycle as a subcomponent. This system is trained end-to-end to
predict ∆G, but does so in a fashion which respects the underlying adsorption thermodynamics. ACNN models were trained
with stochastic gradient descent with a batch size of 24 and the ADAM optimizer20 for 100 epochs.
Baseline Comparison
Grid Featurizer Method
The grid featurization method (GRID), first introduced in molecular machine learning benchmark MoleculeNet21, was chosen
as the baseline method for comparison of structure-based machine learning methods. The GRID method incorporates both
the ligand and target protein structural information by considering both the chemical interaction within the binding pocket
as well as features of the protein and ligand individually. The grid featurizer was inspired by the NNscore featurizer10 and
SPLIF22 but optimized for speed, robustness, and generalizability. The molecular interactions enumerated by the GRID method
include salt bridges and hydrogen bonding between protein and ligand, intra-ligand circular fingerprints23, intra-protein circular
fingerprints, and protein-ligand SPLIF fingerprints.
The features produced by GRID were used to create a random forest regression model (GRID-RF) and a fully-connected
neural network model (GRID-NN). Random forest models were trained using the scikit-learn RandomForestRegressor.
Fully-connected neural network models were trained using the DeepChem TensorflowMultitaskRegressor. Model
hyperparameters are described elsewhere21. The GRID method in conjunction with the random forest regression model is
currently the top performing machine learning method for structure-based binding affinity prediction on the PDBBind dataset
contained within the MoleculeNet benchmark.
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Graph Convolution Method
The graph convolutional neural network (GCNN) of Duvenaud and Maclaurin13 was chosen as a baseline for ligand-based
convolutional deep learning methods. Graph convolutional models treat molecules as undirected graphs whose vertices and
edges represent individual atoms and bonds. A graph convolutional layer applies the same learnable function to every atom in
the graph, resulting in a learned featurization. The graph convolutional algorithm is similar in spirit to the ACNN, but uses the
bonded connectivity graph instead of a spatial neighbor list. Put another way, the GCNN is purely two dimensional, while the
ACNN is natively a three dimensional architecture. Descriptions of the graph convolutional models and model hyperparameters
are given elsewhere in the literature21.
ECFP Fingerprint Method
The extended-connectivity fingerprints23 (ECFP) featurization method was chosen as a baseline for ligand-based machine
learning methods. ECFPs are widely-used molecular characterizations in chemical informatics. The ECFP featurization
process decomposes a molecule into segments originated from non-hydrogen atoms, each assigned with a unique identifier.
These segments and identifiers are extended through bonds to generate larger substructures and corresponding identifiers. The
substructures are hashed into a fixed length binary fingerprint.
The features produced by ECFP were used to create a random forest regression model (ECFP-RF) and a fully-connected
neural network model (ECFP-NN). Random forest models were trained using the scikit-learn RandomForestRegressor.
Fully-connected neural network models were trained using the DeepChem TensorflowMultitaskRegressor. Model
hyperparameters are described elsewhere21.
Datasets
PDBBind17, 24 is a database of experimentally measured binding affinities for protein ligand complexes. PDBBind provides 3D
crystal structures and associated inhibition constant Ki for the protein-ligand complexes in its collection. The PDBBind 2015
dataset contains three subsets: core (195 structures), refined (3,706 structures), and full (14,260). The crystal structures present
in the refined datasets are obtained at a higher resolution and cleaned more thoroughly than the full dataset, in addition to more
stringent requirements on the quality of the complex structure, quality of the binding data, and the nature of the complex. The
complexes present in the refined set are then clustered by 90% similarity in protein sequence to create 65 families. From these
families, the core set was created by selecting three representative complexes (weakest binding, median binding, and strongest
binding) to control sample redundancy. Additional information on the curation of these datasets can be found elsewhere25.
We use the core and refined subsets to train and benchmark the performance of ACNNs. Other popular protein-ligand scoring
functions trained on the PDBBind dataset include X-Score26 and AutoDock Vina4.
Dataset Splitting
We consider four methods of splitting PDBBind core and refined sets into subsets for train/test evaluation: random, stratified,
scaffold, and temporal. All train/test splits follow the 80/20 ratio. Splits were performed with a fixed random seed for
reproducibility and to ensure all models are trained and evaluated on the same data. The random split randomly splits samples
into train/test subsets. The stratified split sorts examples in order of increasing inhibition constant Ki, and then choses samples
10 at a time and randomly splits these samples into train/test subsets to ensure that each set contains the full range of inhibition
constant present in the parent dataset. Scaffold splitting was performed using Bemis-Murcko ligand scaffold clustering27. This
procedure clusters ligand molecules present in the datasets by removing side chain atoms and sorting by scaffold frequency.
Common scaffolds are placed in the train set and uncommon scaffolds are placed in the test set. Since this split attempts to
separate structurally distinct molecules into train and test sets, it represents a much greater challenge for learning algorithms
compared with random and stratified split. Temporal splitting was performed based on the year that the protein-ligand complex
was entered in the Protein Data Bank. This split tests the ability of the learning algorithm to use prior historical data to predict
results of future experiments, similar to typical use in prospective drug discovery. The random, stratified, and scaffold splits are
explained in much greater detail in the MoleculeNet21 benchmark.
Performance Metrics
To determine the train and test set performance, the squared Pearson correlation coefficient (R2) of logKi and binding free
energy mean unsigned error were evaluated. Raw scatter plots comparing the actual and predicted logKi for all datasets and
splits using the ACNN and GRID-RF methods are given in Supplementary Information.
Discussion and Results
The results of model training and evaluation on the PDBBind core set are shown in Tables 1 and 2. All ACNN core set models
were trained with 15 atom types, 3 radial filters, and a (32, 32, 16) pyramidal atomistic fully-connected layer. ACNN models
show comparable or better performance with GRID-RF across all data splits in both Pearson R2 and mean absolute error
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ACNN GRID-RF GRID-NN GCNN ECFP-RF ECFP-NN
Split Train Test Train Test Train Test Train Test Train Test Train Test
Random .912 .448 .969 .336 .963 .058 .676 .265 .920 .212 .942 .227
Stratified .939 .116 .969 .132 .963 .165 .735 .064 .924 .071 .942 .077
Scaffold .911 .043 .965 .109 .953 .067 .797 .254 .920 .218 .940 .206
Temporal .923 .251 .972 .287 .957 .245 .744 .095 .925 .206 .952 .071
Table 1. Performance (Pearson R2) on PDBBind core train/test sets.
ACNN GRID-RF GRID-NN GCNN ECFP-RF ECFP-NN
Split Train Test Train Test Train Test Train Test Train Test Train Test
Random 0.325 0.774 0.385 0.741 0.230 0.877 0.656 1.112 0.399 1.112 0.234 1.138
Stratified 0.282 0.997 0.339 0.990 0.205 0.813 0.556 0.995 0.410 0.901 0.223 1.115
Scaffold 0.410 0.993 0.338 1.397 0.211 1.630 0.516 0.883 0.438 1.003 0.221 0.909
Temporal 0.363 0.974 0.368 0.860 0.237 0.809 0.588 1.062 0.413 0.974 0.341 1.265
Table 2. Performance (MUE [kcal/mol]) on PDBBind core train/test sets.
metrics. Mean absolute error metrics across all splits within the structure-based methods (ACNN, GRID-RF, GRID-NN) are all
comparable, with the exception of scaffold split where ACNN models demonstrate better test performance. The ligand-based
baselines (GCNN, ECFP-RF, ECFP-NN) all exhibit strong train performance, but inferior test performance and fail to generalize
well compared with structure-based models due to the lack of features representing protein structure. One notable exception is
the performance of GCNN on the scaffold split core test set, which performs best out of all methods across both metrics.
In all ACNN core set models, the mean absolute error on the test set is less than 1 kcal/mol, a barrier which has been
previously cited as chemical accuracy necessary to enable rapid computational drug design.28 The demonstrated performance
indicates that ACNN models are able to learn chemical interactions from relatively few (less than 160) datapoints. However, in
all core set models, there is a large gap between train and test performance, indicating that overfitting is a general problem in
these models, and that either more data or better parameter regularization is required.
The results of model training and evaluation on the PDBBind refined set are shown in Tables 3 and 4. All ACNN refined
set models were trained with 25 atom types, 5 radial filters, and a (128, 128, 64) pyramidal atomistic fully-connected layer.
Learnable parameter regularization was enforced by the Dropout method29, with a dropout probability of 40% applied to all
but the final fully connected layer. ACNN models exhibit comparable Pearson R2 and nearly identical mean absolute error
performance on the refined datasets compared with GRID models. The addition of Dropout to the ACNN models does improve
generalizability between train and test sets across all splits, and the maximum mean unsigned error of the ACNN models across
all test sets is less than 1 kcal/mol. In general, end-to-end trained models (ACNN and GCNN) exhibit the best generalization
between train and test. Ligand-based baselines do well compared to structure-based mathods on the refined dataset, also
exhibiting mean unsigned error less than 1 kcal/mol across all splits. Even without protein structure, these methods are able to
discern what is and what isn’t a potent drug-like molecule.
The largest shortcoming of the ACNN models in the current work is the inability to learn better from larger PDBBind
datasets. Since the ACNN models are featurized based on raw atomic coordinates, rather than interaction counts and molecular
graph fingerprints, they are more susceptible to incorrect learning due to noise in experimental crystal structure. ACNN models
trained on the full PDBBind set, which has much looser requirements on the completeness and accuracy of structural data and
binding constants, do not exhibit smooth loss convergence, and train/test performance can show large fluctuations even at long
train times. The degradation of performance due to structural data can be improved by including more, higher-quality crystal
structures and binding free energy measurements or through systematic structural refinement with, for example, a molecular
force field in addition to the inclusion of multiple ligand binding conformations per complex.
We anticipate the current ACNN models will exhibit worse performance when trained models are applied well-outside the
scope of training data, forcing the model to extrapolate rather than interpolate. This includes new atom types, interaction types,
ligand scaffolds, and protein binding pockets that differ greatly than those included in the training set. The poor performance on
predicting the binding affinity of unseen scaffolds is an issue with all methods tested in this study. The improved performance of
ACNN models over traditional ML approaches on the core dataset suggest that ACNN models can be retrained with relatively
few data points on systems of interest outside of the original training set to boost predictive power.
Early experiments with weight regularization techniques such as Dropout and L2/L1 regularization suggest that model
overfitting and test set performance are highly sensitive to regularization strength and technique. Increasing number of
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ACNN GRID-RF GRID-NN GCNN ECFP-RF ECFP-NN
Split Train Test Train Test Train Test Train Test Train Test Train Test
Random .705 .508 .962 .546 .976 .539 .581 .403 .883 .466 .850 .386
Stratified .793 .491 .963 .562 .983 .494 .635 .410 .883 .477 .840 .462
Scaffold .752 .267 .964 .349 .977 .334 .652 .135 .861 .229 .824 .146
Temporal .704 .529 .963 .486 .978 .455 .596 .315 .875 .401 .827 .362
Table 3. Performance (Pearson R2) on PDBBind refined train/test sets.
ACNN GRID-RF GRID-NN GCNN ECFP-RF ECFP-NN
Split Train Test Train Test Train Test Train Test Train Test Train Test
Random 0.518 0.653 0.240 0.630 0.468 1.208 0.598 0.726 0.319 0.661 0.335 0.740
Stratified 0.540 0.686 0.237 0.650 0.439 1.109 0.559 0.710 0.319 0.660 0.344 0.678
Scaffold 0.555 0.579 0.245 0.537 0.406 1.177 0.557 0.805 0.339 0.749 0.373 0.856
Temporal 0.526 0.668 0.235 0.666 0.410 1.184 0.610 0.865 0.321 0.770 0.371 0.798
Table 4. Performance (MUE [kcal/mol]) on PDBBind refined train/test sets.
parameters beyond what was presented in the paper leads to overfitting on train and reduced performance on test. The addition
of regularization techniques may also help ACNN models become less sensitive to noise in structural and thermodynamic
data and reduce overfitting. A systematic cross-validation study of model architecture and weight regularization is currently
underway.
We argue that ACNNs represent a fundamental advance in protein-ligand affinity prediction due to the fact that they utilize a
fully-differentiable end-to-end learned representation. In machine translation, Bahdanau et al.30 introduced the first end-to-end
neural machine translation architecture. This architecture was the first fully-differentiable system for machine translation. In its
first iteration, the model only performed at par with older machine translation systems (much as ACNNs only perform at par
with simpler machine learning baselines). However, with two years of refinement, the latest neural machine translation system
has been deployed in Google Translate31 and led to dramatic improvements of 60% relative to the older system. We believe that
a similar potential for improvement exists with atomic convolutions.
Finally, we note that ACNNs should also be applicable to a number of applications not directly related to drug discovery. For
example, ACNNs may be able to improve upon existing neural network-based potentials for the automated fitting of potential
energy surfaces (force fields), which have wide applicability in theoretical chemistry for accelerating ab-initio molecular
dynamics simulations of many-body systems. By introducing a learnable, convolutional 3-D atomic fingerprint and neighbor
list routine to the existing atomic neural network potential, the accuracy and computational tractability of models are vastly
improved. Additionally, ACNNs are a general featurization technique that should perform well on traditional virtual screening
tasks where 3-D structural information is required, such as the prediction of electronic properties of molecules9 and the virtual
screening of new materials, such as organic photovoltaics32 and light-emitting diodes33.
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Figure 3. ACNN Performance on core training set. Comparison between experimental and predicted logKi evaluated on
PDBBind core (a) Random (b) Stratified (c) Scaffold and (d) Temporal train sets.
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Figure 4. ACNN Performance on core test set. Comparison between experimental and predicted logKi evaluated on
PDBBind core (a) Random (b) Stratified (c) Scaffold and (d) Temporal test sets.
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Figure 5. GRID-RF Performance on core training set. Comparison between experimental and predicted logKi evaluated
on PDBBind core (a) Random (b) Stratified (c) Scaffold and (d) Temporal train sets.
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Figure 6. GRID-RF Performance on core test set. Comparison between experimental and predicted logKi evaluated on
PDBBind core (a) Random (b) Stratified (c) Scaffold and (d) Temporal test sets.
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Figure 7. ACNN Performance on refined training set. Comparison between experimental and predicted logKi evaluated on
PDBBind refined (a) Random (b) Stratified (c) Scaffold and (d) Temporal train sets.
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Figure 8. ACNN Performance on refined test set. Comparison between experimental and predicted logKi evaluated on
PDBBind refined (a) Random (b) Stratified (c) Scaffold and (d) Temporal test sets.
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Figure 9. GRID-RF Performance on refined training set. Comparison between experimental and predicted logKi
evaluated on PDBBind refined (a) Random (b) Stratified (c) Scaffold and (d) Temporal train sets.
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Figure 10. GRID-RF Performance on refined test set. Comparison between experimental and predicted logKi evaluated on
PDBBind refined (a) Random (b) Stratified (c) Scaffold and (d) Temporal test sets.
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